Page 30 - GTM-1-2

Global Translational Medicine IGF-1 and IGFBP-3 levels are correlated with eGFR

34. Kratzsch J, Keliner K, Zilkens T, et al., 1996, Growth 41. Suda K, Matsumoto R, Fukuoka H, et al., 2016, The influence of
hormone-binding protein related immunoreactivity is Type 2 diabetes on serum GH and IGF-I levels in hospitalized
regulated by the degree of insulinopenia in diabetes mellitus. Japanese patients. Growth Horm IGF Res, 29: 4–10.
Clin Endocrinol (Oxf), 44: 673–678.
https://doi.org/10.1016/j.ghir.2016.03.002
https://doi.org/10.1046/j.1365-2265.1996.672494.x
42. Weil EJ, Kobes S, Jones LI, et al., 2019, Glycemia affects
35. Jorgensen JO, Pedersen SA, Thuesen L, et al., 1989, Beneficial glomerular filtration rate in people with Type 2 diabetes.
effects of growth hormone treatment in GH-deficient adults. BMC Nephrol, 20: 397.
Lancet, 1: 1221–1225.
43. Barter P, Gotto AM, LaRosa JC, et al., 2007, HDL cholesterol,
https://doi.org/10.1016/s0140-6736(89)92328-3 very low levels of LDL cholesterol, and cardiovascular
36. Miyauchi S, Miyake T, Miyazaki M, et al., 2019, Insulin-like events. N Engl J Med, 357: 1301–1310.
growth factor-1 is inversely associated with liver fibrotic https://doi.org/10.1056/NEJMoa064278
markers in patients with Type 2 diabetes mellitus. J Diabetes
Investig, 10: 1083–1091. 44. Kosmas CE, Martinez I, Sourlas A, et al., 2018, High-
density lipoprotein (HDL) functionality and its relevance
https://doi.org/10.1111/jdi.13000 to atherosclerotic cardiovascular disease. Drugs Context,
37. Maximus PS, 2019, Insulin like growth factor 1 is linked 7: 212525.
to higher cardiovascular risk score in adults with Type 2 https://doi.org/10.7573/dic.212525
diabetes mellitus and chronic kidney disease. Diabetes
Metab Syndr, 13: 2613–2618. 45. Gordon DJ, Probstfield JL, Garrison RJ, et al., 1989, High-
density lipoprotein cholesterol and cardiovascular disease.
https://doi.org/10.1016/j.dsx.2019.07.008 Four prospective American studies. Circulation, 79: 8–15.
38. Sandhu MS, Heald AH, Gibson JM, et al., 2002, https://doi.org/10.1161/01.cir.79.1.8
Circulating concentrations of insulin-like growth factor-I
and development of glucose intolerance: A prospective 46. Teppala S, Shankar A, 2010, Association between serum
observational study. Lancet, 359: 1740–1745. IGF-1 and diabetes among U.S. adults. Diabetes Care,
33: 2257–2259.
https://doi.org/10.1016/S0140-6736(02)08655-5
https://doi.org/10.2337/dc10-0770
39. Simila ME, Kontto JP, Virtamo J, et al., 2019, Insulin-like
growth factor I, binding proteins-1 and-3, risk of Type 2 47. Song X, Teng J, Wang A, et al., 2016, Positive correlation
diabetes and macronutrient intakes in men. Br J Nutr, between serum IGF-1 and HDL-C in Type 2 diabetes
121: 938–944. mellitus. Diabetes Res Clin Pract, 118: 44–49.
https://doi.org/10.1017/S0007114519000321 https://doi.org/10.1016/j.diabres.2016.04.056
40. Aleidi SM, Shayeb E, Bzour J, et al., 2019, Serum level of 48. Wang X, Tian F, Sun H, et al., 2019, Insulin-like growth
insulin-like growth factor-I in Type 2 diabetic patients: factor-1 as a nutritional monitoring factor in patients with
Impact of obesity. Horm Mol Biol Clin Investig, 39: 20190015. chronic intestinal failure. Clin Nutr, 38: 1737–1744.
https://doi.org/10.1515/hmbci-2019-0015 https://doi.org/10.1016/j.clnu.2018.07.031

Volume 1 Issue 2 (2022) 10 https://doi.org/10.36922/gtm.v1i2.62